The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jiang, Y.
Right arrow Articles by Clayberger, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jiang, Y.
Right arrow Articles by Clayberger, C.
Right arrowPubmed/NCBI databases
*Substance via MeSH
The Journal of Immunology, 2002, 168: 3323-3328.
Copyright © 2002 by The American Association of Immunologists

DQ 65–79, a Peptide Derived from HLA Class II, Induces I{kappa}B Expression1

Yun Jiang*, Daniel Chen{dagger}, Shu-Chen Lyu*, Xuefeng Ling{dagger}, Alan M. Krensky{dagger} and Carol Clayberger2,*,{dagger}

* Department of Cardiothoracic Surgery and {dagger} Division of Immunology and Transplantation Biology, Department of Pediatrics, Stanford University, Stanford, CA 94305

A synthetic peptide corresponding to residues 65–79 of the {alpha} helix of the {alpha}-chain of the class II HLA molecule DQA03011 (DQ 65–79) inhibits the proliferation of human T lymphocytes in an allele nonrestricted manner. By using microarray technology, we found that expression of 29 genes was increased or decreased in a human CTL cell line after treatment with DQ 65–79. This study focuses on one of these genes, I{kappa}B-{alpha}, whose expression is increased by DQ 65–79. I{kappa}B proteins, including I{kappa}B-{alpha} and I{kappa}B-{beta}, are increased in T cells treated with DQ 65–79. Nuclear translocation of the NF-{kappa}B subunits p65 and p50 is decreased in T cells after treatment with DQ 65–79, while elevated levels of p65 and p50 are present in cytosol. DQ 65–79 inhibits the degradation of I{kappa}B-{alpha} mRNA and inhibits the activity of I{kappa}B kinase. These findings indicate that the DQ 65–79 peptide increases the level of I{kappa}B proteins, thereby preventing nuclear translocation of the transcription factor, NF-{kappa}B, and inhibiting T cell proliferation.




This article has been cited by other articles:


Home page
Nephrol Dial TransplantHome page
M. Cohen-Lahav, S. Shany, D. Tobvin, C. Chaimovitz, and A. Douvdevani
Vitamin D decreases NF{kappa}B activity by increasing I{kappa}B{alpha} levels
Nephrol. Dial. Transplant., April 1, 2006; 21(4): 889 - 897.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. Dong, S.-C. Lyu, A. M. Krensky, and C. Clayberger
DQ 65-79, A Peptide Derived from HLA Class II, Mimics p21 to Block T Cell Proliferation
J. Immunol., November 15, 2003; 171(10): 5064 - 5070.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.